A phase I clinical trial to evaluate the safety and immunogenicity of a 6-plasmid multiclade HIV-1 DNA vaccine, VRC-HIVDNA016-00-VP, in uninfected adult volunteers
Phase of Trial: Phase I
Latest Information Update: 31 Jan 2017
At a glance
- Drugs VRC-HIVDNA016-00-VP (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 16 Jan 2008 Status changed from in progress to completed.
- 27 Jun 2006 New trial record.